Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Microscopy Method Enables Detailed Whole Brain 3D RNA Analysis

By LabMedica International staff writers
Posted on 26 Nov 2024

Despite significant advancements in RNA analysis, linking RNA data to its spatial context, particularly in intact, detailed three-dimensional (3D) tissue volumes, has remained a challenging task. More...

Researchers have now developed a microscopy technique that allows for detailed 3D RNA analysis at the cellular level within whole, intact mouse brains. This new method, known as TRISCO, has the potential to revolutionize our understanding of brain function in both healthy and diseased states, as demonstrated in a study published in Science.

The TRISCO technique, developed by researchers at Karolinska Institutet (Stockholm, Sweden) and Karolinska University Hospital (Stockholm, Sweden), enables 3D RNA imaging of entire mouse brains without requiring the brain to be sliced into thin sections, which was a necessary step in previous methods. In the study, up to three different RNA molecules were analyzed simultaneously. The researchers plan to expand this technique to analyze approximately one hundred RNA molecules using multiplex RNA analysis, which could provide even deeper insights into brain function and disease mechanisms.

The TRISCO method opens up new avenues for studying the intricate complexity of the brain, potentially leading to the development of novel treatments for a variety of brain disorders. While the study focused on intact mouse brains, it also shows that the TRISCO method is adaptable to larger brains, such as those of guinea pigs, as well as various tissues, including the kidney, heart, and lungs.

“This method is a powerful tool that can drive brain research forward. With TRISCO, we can study the complex anatomical structure of the brain in a way that was previously not possible,” said Per Uhlén, professor at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and the study's last author.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.